guanosine-triphosphate and guanosine-5--diphosphate-3--monophosphate

guanosine-triphosphate has been researched along with guanosine-5--diphosphate-3--monophosphate* in 3 studies

Other Studies

3 other study(ies) available for guanosine-triphosphate and guanosine-5--diphosphate-3--monophosphate

ArticleYear
Basal levels of (p)ppGpp in Enterococcus faecalis: the magic beyond the stringent response.
    mBio, 2013, Sep-24, Volume: 4, Issue:5

    The stringent response (SR), mediated by the alarmone (p)ppGpp, is a conserved bacterial adaptation system controlling broad metabolic alterations necessary for survival under adverse conditions. In Enterococcus faecalis, production of (p)ppGpp is controlled by the bifunctional protein RSH (for "Rel SpoT homologue"; also known as RelA) and by the monofunctional synthetase RelQ. Previous characterization of E. faecalis strains lacking rsh, relQ, or both revealed that RSH is responsible for activation of the SR and that alterations in (p)ppGpp production negatively impact bacterial stress survival and virulence. Despite its well-characterized role as the effector of the SR, the significance of (p)ppGpp during balanced growth remains poorly understood. Microarrays of E. faecalis strains producing different basal amounts of (p)ppGpp identified several genes and pathways regulated by modest changes in (p)ppGpp. Notably, expression of numerous genes involved in energy generation were induced in the rsh relQ [(p)ppGpp(0)] strain, suggesting that a lack of basal (p)ppGpp places the cell in a "transcriptionally relaxed" state. Alterations in the fermentation profile and increased production of H2O2 in the (p)ppGpp(0) strain substantiate the observed transcriptional changes. We confirm that, similar to what is seen in Bacillus subtilis, (p)ppGpp directly inhibits the activity of enzymes involved in GTP biosynthesis, and complete loss of (p)ppGpp leads to dysregulation of GTP homeostasis. Finally, we show that the association of (p)ppGpp with antibiotic survival does not relate to the SR but rather relates to basal (p)ppGpp pools. Collectively, this study highlights the critical but still underappreciated role of basal (p)ppGpp pools under balanced growth conditions.. Drug-resistant bacterial infections continue to pose a significant public health threat by limiting therapeutic options available to care providers. The stringent response (SR), mediated by the accumulation of two modified guanine nucleotides collectively known as (p)ppGpp, is a highly conserved stress response that broadly remodels bacterial physiology to a survival state. Given the strong correlation of the SR with the ability of bacteria to survive antibiotic treatment and the direct association of (p)ppGpp production with bacterial infectivity, understanding how bacteria produce and utilize (p)ppGpp may reveal potential targets for the development of new antimicrobial therapies. Using the multidrug-resistant pathogen Enterococcus faecalis as a model, we show that small alterations to (p)ppGpp levels, well below concentrations needed to trigger the SR, severely affected bacterial metabolism and antibiotic survival. Our findings highlight the often-underappreciated contribution of basal (p)ppGpp levels to metabolic balance and stress tolerance in bacteria.

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Energy Metabolism; Enterococcus faecalis; Fermentation; Guanine Nucleotides; Guanosine Triphosphate; Hydrogen Peroxide; Stress, Physiological

2013
2.0 A crystal structure of human ARL5-GDP3'P, a novel member of the small GTP-binding proteins.
    Biochemical and biophysical research communications, 2005, Jul-08, Volume: 332, Issue:3

    ARL5 is a member of ARLs, which is widespread in high eukaryotes and homologous between species. But no structure or biological function of this member is reported. We expressed, purified, and resolved the structure of human ARL5 with bound GDP3'P at 2.0 A resolution. A comparison with the known structures of ARFs shows that besides the typical features of ARFs, human ARL5 has specific features of its own. Bacterially expressed human ARL5 contains bound GDP3'P which is seldom seen in other structures. The hydrophobic tail of the introduced detergent Triton X-305 binds at the possible myristoylation site of Gly2, simulating the myristoylated state of N-terminal amphipathic helix in vivo. The structural features of the nucleotide binding motifs and the switch regions prove that ARL5 will undergo the typical GDP/GTP structural cycle as other members of ARLs, which is the basis of their biological functions.

    Topics: ADP-Ribosylation Factors; Amino Acid Motifs; Binding Sites; Crystallography, X-Ray; Guanine Nucleotides; Guanosine Diphosphate; Guanosine Triphosphate; Humans; Macromolecular Substances; Models, Molecular; Protein Conformation; Recombinant Proteins; Static Electricity

2005
Effect of unusual guanosine nucleotides on the activities of some Escherichia coli cellular enzymes.
    Biochimica et biophysica acta, 1981, Nov-05, Volume: 677, Issue:3-4

    Unusual guanosine nucleotides guanosine 5'-diphosphate 3'-diphosphate (ppGpp, also known as MSI) and guanosine 5'-diphosphate 3'-monophosphate (ppGp, also known as MSIII) accumulate to high concentrations in wild-type cells of Escherichia coli during amino acid starvation. We reported here that both nucleotides strongly inhibit the activity of enzymes IMP dehydrogenase and adenylosuccinate synthetase, the first enzymes of the guanylate and adenylate biosynthetic pathways. In both cases, ppGP (MSII) is a stronger inhibitor than ppGpp (MSI). On the other hand, these two nucleotides exhibited opposite effects on the activity of phosphoenolpyruvate carboxylase, the enzyme that utilizes phosphoenolpyruvate. At their respective physiological concentrations, the activity of phosphoenolpyruvate carboxylase is activated by ppGpp and inhibited by ppGp.

    Topics: Adenylosuccinate Synthase; Enzyme Activation; Escherichia coli; Guanine Nucleotides; Guanosine Diphosphate; Guanosine Tetraphosphate; Guanosine Triphosphate; IMP Dehydrogenase; Phosphoenolpyruvate Carboxylase

1981